chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: FLUN4
Symptoms: Angioedema, Swelling face
Clinical narrative: A report has been received from a Physician concerning a 33 year old, Female patient. Patient's concomitant medication was not reported. The patient's medical history included chronic psoriasis. Patient had been receiving nasal FLUMIST (intranasal) started on 13-Oct-2014. Physician reported that patient experienced facial angioedema which started on 13-Oct-2014 after receiving FLUMIST. This was the patient's first experience with FLUMIST. Within 12 hours the patient developed bilateral swelling of the face and was diagnosed with angioedema. The patient was treated with steroids and symptoms improved. The patient missed a dose and symptoms returned, but improved again after resuming the steroids. Currently the patient still had symptoms: different areas of the face swell at different times. The patient was still taking steroids. Action taken with FLUMIST was unknown. At the time of reporting, the event of facial angioedema was ongoing. The reporter considered the event to be non-serious. Physician thought it was unlikely to be a reaction from the vaccine since it has lasted so long. Company physician agreed with the provided reporter causality between the event facial angioedema and FLUMIST to be not related. Corrected report 24-Mar-2015: AZ receive date updated to 24-Dec-2014, form completed date amended to 24-Dec-2015.
Sex: U
Vaccine: MMR, VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. On 17-JUL-2015, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX lot # L000454 with exp. 06-JAN-2017, (route and dose were not provided). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 0.83
Sex: M
Vaccine: HEP, HEP
Symptoms: Haemophilus test positive, Inability to crawl, Inflammatory marker increased, Injection site erythema, Injection site swelling
Clinical narrative: Developed MRI proven fascitis and myositis at site of vaccine administration (left thigh). Blood cx x 2 have grown H. influenzae (type still pending).
Age: 0.83
Sex: M
Vaccine: HEP, HEP
Symptoms: Pyrexia, Rhinorrhoea, Staphylococcus test positive, Vomiting, Weight bearing difficulty
Clinical narrative: Developed MRI proven fascitis and myositis at site of vaccine administration (left thigh). Blood cx x 2 have grown H. influenzae (type still pending).
Age: 0.83
Sex: M
Vaccine: HEP, HEP
Symptoms: Fasciitis, Haemophilus test positive, Injection site joint effusion, Injection site oedema, Myositis
Clinical narrative: Developed MRI proven fascitis and myositis at site of vaccine administration (left thigh). Blood cx x 2 have grown H. influenzae (type still pending).
Age: 0.83
Sex: M
Vaccine: HEP, HEP
Symptoms: Nuclear magnetic resonance imaging abnormal, Vaccination site reaction
Clinical narrative: Developed MRI proven fascitis and myositis at site of vaccine administration (left thigh). Blood cx x 2 have grown H. influenzae (type still pending).
Age: 59.0
Sex: F
Vaccine: TDAP
Symptoms: Hallucination, Hyperhidrosis, Pain, Pyrexia, Tremor
Clinical narrative: Body aches, fever (40.0 C), shakes, sweating, waking with hallucinations of people she knew.
Age: 39.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: SWELLING AND REDNESS AT SITE OF INJECTION.
Age: 87.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Localized eythema, edema left deltoid.
Age: 40.0
Sex: F
Vaccine: HEPA
Symptoms: Computerised tomogram, Dizziness, Laboratory test, Nuclear magnetic resonance imaging, Vertigo
Clinical narrative: Severe vertigo/dizziness.
Age: 20.0
Sex: M
Vaccine: MNQ
Symptoms: Dyspnoea, Injection site pain, Neck pain, Oropharyngeal pain, Pain
Clinical narrative: Sore at injection site. Sore shoulder same side as injection. Sore neck. Fever. Runny nose. Hurts to look down. Sore throat. Extremely difficult to breath.
Age: 20.0
Sex: M
Vaccine: MNQ
Symptoms: Pyrexia, Rhinorrhoea, Throat irritation
Clinical narrative: Sore at injection site. Sore shoulder same side as injection. Sore neck. Fever. Runny nose. Hurts to look down. Sore throat. Extremely difficult to breath.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Discomfort, Injection site swelling, Swelling, Tenderness
Clinical narrative: Patient returns with his mother for evaluation of left arm swelling. He received his Kinrix in the left deltoid about 72 hours ago. Technique was correct. Vaccine was correct. Lot and expiration dates are okay. He developed some tenderness and swelling that evening which has progressed over the weekend. he complains of discomfort, shortness, but no major pain. He is not particularly complaining of itching. It is mostly sore when other people push on it. He has no other symptoms. He specifically denies and his mother also denies sore joints, unusual rash, fevers chills or sweats. He has not had any nausea or vomiting. All vital signs are normal with temperature 99.4.
Age: 72.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Injection site reaction, Local reaction, Peripheral swelling, Pruritus
Clinical narrative: Local reaction at injection site.  Arm swollen, red, hot rash extended to entire upper arm.  Itchy red swollen and rash for 9 days.
Age: 72.0
Sex: F
Vaccine: PNC13
Symptoms: Rash, Skin warm
Clinical narrative: Local reaction at injection site.  Arm swollen, red, hot rash extended to entire upper arm.  Itchy red swollen and rash for 9 days.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site swelling
Clinical narrative: Injection site was very swollen and enlarged.
Age: 71.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site pruritus, Injection site reaction, Rash papular
Clinical narrative: Red popular area at site of injection extending 4" below site, itching at site of rash.
Age: 41.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site haematoma, Injection site haemorrhage, Injection site oedema, Injection site pain
Clinical narrative: C/o pain, redness/swelling L deltoid after receiving Tdap on 8/14/2014.  noted redness over the weekend. used some ice. Took Benadryl 8/19/15. Has ecchymosis prox L arm, appears to be over prox deltoid tendon.  Hematoma over L mid deltoid, is TTP.  Skin not hot, normal warm/dry temp to palpate. Has mild erythema, 1+ edema along lower deltoid, just above where she had Ace wrap.  Neg lymphnodes.
Age: 41.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site swelling
Clinical narrative: C/o pain, redness/swelling L deltoid after receiving Tdap on 8/14/2014.  noted redness over the weekend. used some ice. Took Benadryl 8/19/15. Has ecchymosis prox L arm, appears to be over prox deltoid tendon.  Hematoma over L mid deltoid, is TTP.  Skin not hot, normal warm/dry temp to palpate. Has mild erythema, 1+ edema along lower deltoid, just above where she had Ace wrap.  Neg lymphnodes.
Age: 12.0
Sex: U
Vaccine: HPV4
Symptoms: Death
Clinical narrative: This spontaneous report as received from a physician via company representative refers to a 12 year old patient of unknown gender. On an unknown date, the patient was vaccinated with GARDASIL (dose, lot# and route of administration was not reported). No concomitant medication was reported. The physician stated that unspecified person watched television show which reported that on an unknown date the patient died after receiving GARDASIL. Causality assessment was not provided. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Abdominal pain, Blood bilirubin abnormal, Blood creatine phosphokinase, C-reactive protein, Cytomegalovirus test
Clinical narrative: Sudden onset of severe total body muscle aches with abdominal pain; no rash or fever; no treatment; followed abnormal CK and bilirubin; US of belly; EBV and CMV titers (nl); self improved over 10 days.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Cytomegalovirus test negative, Differential white blood cell count, Epstein-Barr virus antibody negative, Full blood count, Hepatitis viral test
Clinical narrative: Sudden onset of severe total body muscle aches with abdominal pain; no rash or fever; no treatment; followed abnormal CK and bilirubin; US of belly; EBV and CMV titers (nl); self improved over 10 days.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Liver function test, Metabolic function test, Myalgia, Red blood cell sedimentation rate, Ultrasound abdomen
Clinical narrative: Sudden onset of severe total body muscle aches with abdominal pain; no rash or fever; no treatment; followed abnormal CK and bilirubin; US of belly; EBV and CMV titers (nl); self improved over 10 days.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Ultrasound pelvis
Clinical narrative: Sudden onset of severe total body muscle aches with abdominal pain; no rash or fever; no treatment; followed abnormal CK and bilirubin; US of belly; EBV and CMV titers (nl); self improved over 10 days.
Age: 16.0
Sex: F
Vaccine: VARCEL
Symptoms: Headache, Tic
Clinical narrative: SEVERE FACIAL TICS HEADACHES HAD VARIVAX.
Age: 54.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site vesicles, Injection site warmth
Clinical narrative: Left upper arm swelling, warth, redness, pain, blister at injection site (unsure of time of onset/time entered because had to put something to proceed in computer).
Age: 4.0
Sex: F
Vaccine: MMRV
Symptoms: Blister, Discomfort, Exposure to communicable disease, Immunology test, Pruritus
Clinical narrative: 8y/o healthy F presented in clinic on 8/21 with Suspected chicken pox in immunized child. Exposure to father with confirmed zoster. Afebrile with large crop of typical vesicles on trunk, limbs and labia. Moderately puritic, but afebrile. Isolation precautions: father to go to peds clinic and pick up two viral transport swabs: Ordered DFA and culture, as sensitivity of DFA not always 100%. Father was confirmed by viral culture. Note Pt was vaccinated wtih Varicella Vaccine 1st dose 12/7/2007 and MMR-Var on 5/2/11. Follow up: confirmed varicella infection (by DFA and PCR). First lesions: August 21 (Friday) 2015. Last new lesions Sunday 8/23/2015. Clinically significant case with 3 distinct crops of vesicles, now numbering more than 200 (close to 300) lesions Fever: low grade only, none higher than 100.4. Patient active, and other than pruritis and discomfort from lesions, no complications (no respiratory, neurologic). Exposure: father with documented zoster 10 days earlier. Risk factors: none identified, nl, healthy 8 year old. Immunization history:  Immunization History  Administered  Date(s) Administered  o DTaP (Diphtheria, Tetanus, acellular Pertussis) 04/18/2007, 02/11/2008  o DTaP-HBV-POL (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Polio) 01/25/2007, 06/05/2007  o DTaP-POL (KINRIX) (Diphtheria, tetanus, acellular pertussis, polio) 05/02/2011  o HAV ped/adol 2 dose sch (Hepatitis A) 12/07/2007, 12/10/2008, 05/02/2011  o HBV (Hepatitis B) 12/02/2006  o HIB PRP-T (Haemophilus influenzae b) 01/25/2007, 04/18/2007, 06/05/2007, 01/07/2010  o INFan (Influenza attenuated virus, intranasal) 10/07/2010, 11/14/2011, 11/13/2012, 11/13/2013, 09/30/2014  o INFan H1N1-09 (Influenza H1N1-09 live attenuated, intranasal) 10/19/2009, 01/07/2010  o INFs pres free 6-35m (Influenza) 10/25/2007, 12/07/2007, 12/10/2008, 09/24/2009  o MMR (Measles, Mumps, Rubella) 12/07/2007  o MMR-VAR (Measles, Mumps, Rubella, Varicella) 05/02/2011  o PNUcn (Pneumococcal conjugate, pneumonia) 01/25/2007, 04/18/2007, 06/05/2007, 02/11/2008  o POL-IPV (Polio, Inactivated virus) 04/18/2007  o ROT5 (Rotavirus live, pentavalent) 01/25/2007, 04/18/2007, 06/05/2007  o VAR (Varicella, chickenpox) 12/07/2007
Age: 4.0
Sex: F
Vaccine: MMRV
Symptoms: Pyrexia, Skin lesion, Varicella post vaccine, Varicella virus test positive
Clinical narrative: 8y/o healthy F presented in clinic on 8/21 with Suspected chicken pox in immunized child. Exposure to father with confirmed zoster. Afebrile with large crop of typical vesicles on trunk, limbs and labia. Moderately puritic, but afebrile. Isolation precautions: father to go to peds clinic and pick up two viral transport swabs: Ordered DFA and culture, as sensitivity of DFA not always 100%. Father was confirmed by viral culture. Note Pt was vaccinated wtih Varicella Vaccine 1st dose 12/7/2007 and MMR-Var on 5/2/11. Follow up: confirmed varicella infection (by DFA and PCR). First lesions: August 21 (Friday) 2015. Last new lesions Sunday 8/23/2015. Clinically significant case with 3 distinct crops of vesicles, now numbering more than 200 (close to 300) lesions Fever: low grade only, none higher than 100.4. Patient active, and other than pruritis and discomfort from lesions, no complications (no respiratory, neurologic). Exposure: father with documented zoster 10 days earlier. Risk factors: none identified, nl, healthy 8 year old. Immunization history:  Immunization History  Administered  Date(s) Administered  o DTaP (Diphtheria, Tetanus, acellular Pertussis) 04/18/2007, 02/11/2008  o DTaP-HBV-POL (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Polio) 01/25/2007, 06/05/2007  o DTaP-POL (KINRIX) (Diphtheria, tetanus, acellular pertussis, polio) 05/02/2011  o HAV ped/adol 2 dose sch (Hepatitis A) 12/07/2007, 12/10/2008, 05/02/2011  o HBV (Hepatitis B) 12/02/2006  o HIB PRP-T (Haemophilus influenzae b) 01/25/2007, 04/18/2007, 06/05/2007, 01/07/2010  o INFan (Influenza attenuated virus, intranasal) 10/07/2010, 11/14/2011, 11/13/2012, 11/13/2013, 09/30/2014  o INFan H1N1-09 (Influenza H1N1-09 live attenuated, intranasal) 10/19/2009, 01/07/2010  o INFs pres free 6-35m (Influenza) 10/25/2007, 12/07/2007, 12/10/2008, 09/24/2009  o MMR (Measles, Mumps, Rubella) 12/07/2007  o MMR-VAR (Measles, Mumps, Rubella, Varicella) 05/02/2011  o PNUcn (Pneumococcal conjugate, pneumonia) 01/25/2007, 04/18/2007, 06/05/2007, 02/11/2008  o POL-IPV (Polio, Inactivated virus) 04/18/2007  o ROT5 (Rotavirus live, pentavalent) 01/25/2007, 04/18/2007, 06/05/2007  o VAR (Varicella, chickenpox) 12/07/2007
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Lymphadenopathy
Clinical narrative: Large (shooter marble) swollen lymph nodes in groin that have not reduced in size even with antibiotics this week.
Age: 62.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Redness itching swelling and pain at injection site spreading and covering left upper arm.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Dizziness, Fall, Hyperhidrosis, Posture abnormal, Vomiting
Clinical narrative: Pt felt faint, slumped onto father's shoulder. No injury from fall. Pt began vomiting and sweating post vaccine administration.
Age: 7.0
Sex: M
Vaccine: FLU4
Symptoms: Blood glucose normal, Dizziness, Feeling abnormal, Pallor, Vomiting
Clinical narrative: Child felt dizzy/faint and turned pale then vomited violently x 4 times. We had the patient lay down in the office for 20 minutes and felt a little better afterwards.
Age: 18.0
Sex: M
Vaccine: MENB
Symptoms: Headache, Nausea, Neck pain, Pain, Vomiting
Clinical narrative: Headaches, neck pain, general body aches, nausea and vomiting.  No treatment required.
Age: 30.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Back pain, Injection site pain, Injection site reaction, Injection site swelling, Nausea
Clinical narrative: Pt c/o fever, L shoulder pain and swelling, body aches, back pain, red rash to shoulder, N/V, swelling in armpit about 3 hours after administration and worsening through 8/25/2015 AM.  Tx'd with ice packs and APA and to return to clinic if sxs persist/exacerbate.
Age: 30.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Oedema peripheral, Pain, Pyrexia, Rash erythematous, Vomiting
Clinical narrative: Pt c/o fever, L shoulder pain and swelling, body aches, back pain, red rash to shoulder, N/V, swelling in armpit about 3 hours after administration and worsening through 8/25/2015 AM.  Tx'd with ice packs and APA and to return to clinic if sxs persist/exacerbate.
Age: 54.0
Sex: F
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Patient called clinic on morning of 8/25/15 and stated she developed "hives" on left arm and left hand approximately 3 hours after MMR vaccine administration (3:30 pm on 8/24/15). Patient came to clinic to be evaluated by the physician on duty. She was then referred to Infectious Disease for further evaluation, who cleared her to return to work and stated reaction was of unknown etiology.
Age: 83.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Injection site reaction, Pruritus, Rash macular, Skin warm
Clinical narrative: Arm is red with red blotches from shoulder to elbow on arm where vaccine was given. Also, arm is itching and warm. No pain.
Age: 0.34
Sex: F
Vaccine: DTPHIB, IPV, PPV, RVX
Symptoms: Diet refusal, Emotional distress, Posture abnormal, Pyrexia, Screaming
Clinical narrative: Loss of head control, could not hold up head on her own, screaming herself to sleep and inconsolable. Refusal to eat and high fever. Shaky.
Age: 0.34
Sex: F
Vaccine: DTPHIB, IPV, PPV, RVX
Symptoms: Tremor
Clinical narrative: Loss of head control, could not hold up head on her own, screaming herself to sleep and inconsolable. Refusal to eat and high fever. Shaky.
Age: 71.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Dysphonia, Fatigue, Ocular hyperaemia, Pain
Clinical narrative: Hoarseness, Red eyes, cough, aches, fatigue.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Musculoskeletal pain, Pain in extremity
Clinical narrative: PATIENT REPORTING SHARP PAIN, AND SORENESS FROM UPPER SHOULDER TO HER FINGER.
Age: 1.03
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Injection site pruritus, Injection site rash
Clinical narrative: Rash on leg, itchiness appeared on 8/14/15.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Body temperature increased, Rash pruritic, Rash vesicular, Scab, Varicella post vaccine
Clinical narrative: Patient broke out in a vesicular rash on 8/13/2015 in the am that was very itchy. Patient was seen by a provider on 8/17/2015 with a 103.4 temp and was diagnosed with Varicella.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Patient had a rash/redness that developed on the back of the arm surrounding the injection site. The rash spread toward the elbow. Patient stated the rash did not appear until 2 days after injection. Patient is being treated by physician with over-the-counter medications.
Age: 1.06
Sex: M
Vaccine: HIBV, MMR, VARCEL
Symptoms: Injection site pruritus, Injection site vesicles
Clinical narrative: Blister on right upper leg. Pruritus.
Age: 59.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Cellulitis, Erythema, Headache, Injected limb mobility decreased, Injection site swelling
Clinical narrative: Severe swelling of arm on injection site, fever, headache, achy. On 08/21/2015, I went to walk-in clinic and was treated for cellulitis.
Age: 59.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pain, Peripheral swelling, Pyrexia, Skin warm
Clinical narrative: Severe swelling of arm on injection site, fever, headache, achy. On 08/21/2015, I went to walk-in clinic and was treated for cellulitis.
Age: 59.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Cellulitis, Dizziness, Epistaxis, Hypotension, Pyrexia
Clinical narrative: Severe swelling of arm on injection site, fever, headache, achy. On 08/21/2015, I went to walk-in clinic and was treated for cellulitis.
Age: 59.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Rash
Clinical narrative: Severe swelling of arm on injection site, fever, headache, achy. On 08/21/2015, I went to walk-in clinic and was treated for cellulitis.
Age: 30.0
Sex: F
Vaccine: FLUC3
Symptoms: Altered state of consciousness, Blood pressure increased, Dizziness, Dyspnoea, Palpitations
Clinical narrative: Within 1/2 hr patient started to have difficulty drawing air in, heart pounding, felt like fainting, about passing out. Her BP elevated to 150/90 mmHg.
Age: 64.0
Sex: F
Vaccine: HEPAB
Symptoms: Injection site induration, Injection site mass, Injection site pain, Injection site reaction, Joint crepitation
Clinical narrative: First shot 10/23/2014 and 2nd shot 04/23/2015 no pain at all. Pain began with the last shot. At the injection site, hard lump, tenderness, nagging bruise like ache, right shoulder joint cracks all the times. Still tender this day hour.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Asthenia, Headache, Limb discomfort, Listless, Pyrexia
Clinical narrative: Thirteen days after receiving the MMR booster she developed a bad headache and 102 fever.  Twelve hours later she began vomiting.  Each time she vomited she would say her head felt better and then the headache would build again until she vomited.  She was very weak, and listless and complained of leg discomfort as well.  This lasted 24 hours and the vomiting ceased but the fever and milder headaches continued for another 24 hours.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Vomiting
Clinical narrative: Thirteen days after receiving the MMR booster she developed a bad headache and 102 fever.  Twelve hours later she began vomiting.  Each time she vomited she would say her head felt better and then the headache would build again until she vomited.  She was very weak, and listless and complained of leg discomfort as well.  This lasted 24 hours and the vomiting ceased but the fever and milder headaches continued for another 24 hours.
Age: 76.0
Sex: F
Vaccine: PNC13
Symptoms: Asthenia, Myalgia, Pain, Pyrexia, Syncope
Clinical narrative: Muscle & body aches all over, fever around 102.1 degrees. Then 2 days later, as patient was trying to make breakfast while still very weak & getting over the illness, she fainted in the kitchen thus hitting her head on the floor.
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Patient received the Zostavax vaccine and 2 days later developed a large hot red bump at the injection site. Treated with ice and NSAIDs.
Age: 80.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Dizziness, Throat irritation, Throat tightness
Clinical narrative: Pt complained of feeling dizzing with a tight and scratchy throat. Pt took oral Benadryl 25mg at 6:20pm.
Age: 79.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site inflammation, Injection site vesicles, Malaise
Clinical narrative: Injection site inflammation, fluid filled vesicle at site of injection, generalized malaise.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Fever, chills, whole body muscle aches, fatigue.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Acne, Blister, Bone pain, Cough, Influenza like illness
Clinical narrative: Patient's arm was sore for day or so before he developed flu like symptoms (Bone aches, cough) with swollen lymph nodes. Patient developed "blistery pimple like hives on right underarm and right chest Feels fine now but still has hives. Patient may see MD in day or two if not resolved.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Lymphadenopathy, Urticaria
Clinical narrative: Patient's arm was sore for day or so before he developed flu like symptoms (Bone aches, cough) with swollen lymph nodes. Patient developed "blistery pimple like hives on right underarm and right chest Feels fine now but still has hives. Patient may see MD in day or two if not resolved.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On an unknown date, the patient was vaccinated with an unspecified improperly stored dose of ROTATEQ, oral, lot # k016263 and expiration date 26-JUN-2016. There were no concomitant medications reported. No adverse experiences reported. No product quality complaint was involved. This is one of several reports from the same source. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Injury associated with device
Clinical narrative: Patient was stuck with a used needle when giving flu shot, no symptoms or signs.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Pain
Clinical narrative: Patient experienced pain 2 days after vaccine was administered. She says the pain has persisted and has not subsided.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Dizziness, Ear pain, Nervousness, Pain in extremity
Clinical narrative: Ears hurt-going to ear Dr. Eyes blurry-saw eye Dr- more floaters. Nervous extremely-called psychiatrist told therapist. Weak areas intensified-went to family doctor weak, dizzy. Legs hurt-seeing vein Dr. Teeth hurt-need crowns.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Toothache, Vasodilatation, Vision blurred, Vitreous floaters
Clinical narrative: Ears hurt-going to ear Dr. Eyes blurry-saw eye Dr- more floaters. Nervous extremely-called psychiatrist told therapist. Weak areas intensified-went to family doctor weak, dizzy. Legs hurt-seeing vein Dr. Teeth hurt-need crowns.
Age: 1.0
Sex: M
Vaccine: HEPA, HIBV
Symptoms: Abnormal behaviour, Autism, Injection site reaction, Pyrexia
Clinical narrative: My son was giving multiple vaccines at one time including, 2 vaccines that are in combination. To come home with a fever and reaction on his leg, then was running into walls.
Age: 15.0
Sex: F
Vaccine: HPV9
Symptoms: Computerised tomogram head normal, Fall, Head injury, Laceration, Loss of consciousness
Clinical narrative: Pt developed loss of consciousness within a minute of vaccine administered. Resulted in fall from exam table, hit head and had lacerations.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Cyanosis, Laboratory test normal, Vasodilatation
Clinical narrative: Episodes of apparent cyanosis began hours after vaccines given. (Lips turn blue). Presented to the ER day after vaccines. Admitted x 3 days witnessed event: not cyanosis. Just physiologic vasodilation.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Swelling
Clinical narrative: Red size of golf ball (diameter), puffy, 3 inches above elbow-about 6 hours after shot no treatment needed.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Ear swelling, Erythema, Eye swelling, Feeling abnormal, Ocular hyperaemia
Clinical narrative: Behind Lt ear red, swollen. Bil eyes swelled, red. Felt weird given BENADRYL. Woke up not as swollen.
Age: 51.0
Sex: F
Vaccine: FLU4
Symptoms: Hypersensitivity
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of allergic reaction in a 51-year-old female patient who received FLUARIX QUADRIVALENT (batch number 34CY2, expiry date 30th June 2015). In 2014, the patient received FLUARIX QUADRIVALENT. On an unknown date, an unknown time after receiving FLUARIX QUADRIVALENT, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown. The reporter considered the allergic reaction to be related to FLUARIX QUADRIVALENT. Additional details were as follows: This case was previously reported to a doctor. The reporter was told by her physician that a patient received the FLUARIX QUADRIVALENT vaccine last fall (2014) and she experienced an allergic reaction. The reporter did not have any details because the patient was new to their practice and she did not received the vaccine from them. The reporter was told by her physician to call GlaxoSmithKline to determine which flu vaccines do not contain egg products.
Age: 7.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug ineffective, Influenza, Influenza A virus test positive
Clinical narrative: A report from a Health Professional concerns a 7 year old female patient. Medical history and concomitant medication were not reported. On 17-Oct-2014 received FLUMIST QUADRIVALENT (intranasal). Lot number was CJ2127 and expiry date of 31-Dec-2014. Patient had Influenza A test and result was positive with a diagnosis of influenza A which started on 22-Dec-2014. Further, there was worsening of flu symptoms. Patient was treated with TAMIFLU. The outcome of the influenza A and lack of efficacy was unknown. The company physician identified and assessed the lack of efficacy to be serious as an important medical event and other symptoms to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: A report has been received from a pharmacist concerning a child of unknown gender. The patient's medical history and concomitant medications were not reported. Patient received FLUMIST QUADRIVALENT (intranasal) on an unknown date. It was reported that all the medication came out, past flu season while giving FLUMIST QUADRIVALENT to the child, because the child was laughing and moving the head forward. The outcome of the event of all the medicine came out was unknown. The reporter considered the events to be non-serious.
Age: 24.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A Spontaneous report has been received from a Health Professional concerning a 24 year old, Female patient, who had been receiving FLUMSIT quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. It was reported that the patient describe expired FLUMIST quadrivalent administered which started on 18-Apr-2015. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Incorrect product storage
Clinical narrative: A report has been received from a Health Professional concerning the 100 patients, who had been receiving FLUMIST quadrivalent (intranasal), 0.2mL. On three occasions in FEB2015, their shipment of 100 doses of FLUMIST quadrivalent dropped below 35 degrees in the refrigerator for less than 5 minutes. Specifically, the temperature was 34.9 on 13FEB2015 and 16FEB2015, and 34.7 on 20FEB2015, all for less than 5 minutes. The 100 doses stored outside of temperature parameters were administrated to patients. FLUMIST quadrivalent (intranasal) was continued. The outcome of the event of 100 doses stored outside of temperature parameters were administered to patients was unknown. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Influenza A virus test positive
Clinical narrative: A report has been received from a Health Professional concerning a 14 out of 140 patient, who had been receiving Intramuscular FLUMIST, INTRANASAL), 0.2 Milliliters. Once/Single administration. FLUMIST (INTRANASAL) started on an unknown date. The patient experienced 14 PATIENTS TEST POSITIVE FOR INFLUENZA. The outcome of the event of 14 PATIENTS TEST POSITVE FOR INFLUENZA A was unknown. The report was considered to be non-serious.
Age: 15.0
Sex: M
Vaccine: FLUN4
Symptoms: Influenza A virus test positive
Clinical narrative: A consumer report has been received. The report concerns a 16 year old, Male consumer, who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on 05-Jan-2015. The patient experienced TESTED POSITIVE FOR FLU A which started on 11-Mar-2015. The outcome of the event of TESTED POSITIVE FOR FLU A is unknown. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Influenza virus test positive
Clinical narrative: A report has been received from a Health Professional concerning multiple patients of unknown age and gender, who had been receiving Nasal FLUMIST (INTRANASAL) started on an unknown date. It was reported that SIBLINGS RECEIVED FLUMIST QUAD AND LATER TESTED POSITIVE FOR INFLUENZA THIS SEASON. The outcome of the event of SIBLINGS RECEIVED FLUMIST QUAD AND LATER TESTED POSITIVE FOR INFLUENZA THIS SEASON is unknown. The report was considered to be non-serious by the reporter.
Age: 49.0
Sex: F
Vaccine: FLUN4
Symptoms: Laceration, Peripheral swelling, Syringe issue
Clinical narrative: A report has been received from a Health Professional concerning a 49 year old, Female subject, who had been received Nasal FLUMIST (INTRANASAL). The patient's medical history included SURGERY. Concomitant medications included ANTIBIOTICS for CELLULITIS. FLUMIST (INTRANASAL) started on an unknown date. The patient reported FLUMIST syringe broke in her hand and cut her finger which started on 04-Nov-2014 and bump on her finger. The outcome of the event of BUMP ON HER FINGER and FLUMIST QUADRIVALENT SYRINGE BROKE IN PATIENT'S HAND AND CUT HER FINGER is unknown. The reporter was considered to be non-serious.
Age: 4.0
Sex: U
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Health Professional concerning  4 year old, subject of unknown gender, who had been received FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. The patient had been administered expired FLUMIST quadrivalent, which was considered as medication error, it was states that the expired FLUMIST quadrivalent was one day past date. The outcome of the event of patient has been administered expired FLUMIST quadrivalent was unknown. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Contraindication to vaccination
Clinical narrative: A report has been received from a Health Professional concerning a child, subject of unknown gender, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that the patient child was taking aspirin for a year received FLUMIST QUADRIVALENT. The outcome of the event of child taking aspirin for a year received FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: A report has been received from a Pharmacist concerning a child patient of unknown gender. The patient's medical history and concomitant medications were not reported. Patient received nasal FLUMIST (intranasal) on an unknown date. It was reported that all the medication came out, past flu season while giving FLUMIST to the child, because the child was laughing and moving the head forward. The outcome of the event of all the medicine came out was unknown. The reporter assessed the events to be non-serious.
Age: 49.0
Sex: M
Vaccine: FLUN4
Symptoms: Influenza
Clinical narrative: A spontaneous report has been received from a health professional concerning an adult, male patient. No information regarding the relevant history, concomitant diseases and concomitant drug was provided. The patient over the age of 49 had been receiving nasal FLUMIST (intranasal), started on an unknown date. The patient later developed the flu. The outcome of the event of flu and patient over the age of 49 has been administered FLUMIST was unknown. The reporter considered the event of patient over the age of 49 has been administered FLUMIST to be non-serious. The event flu has been identified by the company physician and has been added as an adverse event which was considered to be non-serious.
Age: 9.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Health Professional concerning a 8 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that patient received an expired dose of FLUMIST QUADRIVALENT that day, which started on 12-Mar-2015. The outcome of the event of expired dose of FLUMIST is unknown. The report was considered to be non-serious. Corrected Report 15-Mar-2015: Order of reporters was corrected. Case narrative corrected.
Sex: U
Vaccine: FLUN4
Symptoms: Incorrect product storage
Clinical narrative: A report had been received from a Health Professional concerning a patient of unknown gender, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. The reporter stated that FLUMIST QUADRIVALENT not stored properly might have been administered to patients. The outcome of the event of FLUMIST QUADRIVALENT not stored properly might have been administered to patients was unknown. The reporter was considered to be non-serious.
Age: 19.0
Sex: F
Vaccine: FLUN4
Symptoms: Chest discomfort, Dyspnoea, Headache, Paraesthesia, Swollen tongue
Clinical narrative: A consumer report has been received. The report concerns a female patient. Patient relevant history, concomitant diseases and concomitant medications were not reported. Patient had been receiving FLUMIST QUADRIVALENT (intranasal) started on 06-Nov-2014. Patient said she received FLUMIST QUADRIVALENT on 06-Nov-14. Two weeks after vaccination she started symptoms of swelling of tongue, difficulty breathing, shortness of breath. She also felt tingling on her hands, legs and head which were more increased close to bedtime. She went to her HCP/MD and to ER due to symptoms. She was told it was probably related to food allergy or anxiety. She was given anti-allergy medication and noticed this meds did not have effect on her symptoms. Then, MD said that her illness was not an allergy reaction or food allergy or anxiety. The symptoms lasted two weeks. After that she noticed that she presents shortness of breath on and off/occasionally. She also confirmed this is the first time she has received FLUMIST QUADRIVALENT. FLUMIST patient reported that after administration in Nov-2014 she developed symptoms of being hard to breathe and feels like something heavy on her chest. She also had a headache. These started 2 weeks after FLUMIST administration and are still occurring. The doctor tells her that everything was normal when they examine her. At the time of reporting, the event of shortness of breath and headache was ongoing and the outcome of the event of swelling of tongue and tingling of hands, legs and head was unknown. The reporter considered the events to be non-serious.
Age: 2.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Physician concerning a 2 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. The reporter stated that the patient experienced expired FLUMIST QUADRIVALENT administered which started on 10-Mar-2015. The outcome of the event expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious.
Age: 9.0
Sex: M
Vaccine: FLUN4
Symptoms: Extra dose administered
Clinical narrative: A report has been received from a Health Professional concerning a patient, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent started on 05-Mar-2015. The patient was administered FLUMIST twice this month. The outcome of the event of administered FLUMIST twice this month is unknown. The report was considered to be non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Influenza virus test positive
Clinical narrative: A report has been received from a Physician concerning a Child, Female subject, who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started during Sep-2014. The patient experienced MD AND HER CHILDREN RECEIVED FLUMIST AND THEN TESTED POSITIVE INFLUENZA which started during Dec-2014. The patient recovered from the event of MD AND HER CHILDREN RECEIVED FLUMIST AND THEN TESTED POSITIVE INFLUENZA on an unspecified date. The report was considered to be non-serious.
Sex: M
Vaccine: FLUN4
Symptoms: Influenza virus test positive
Clinical narrative: A report has been received from a Physician concerning a Child, Male subject who had been received Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started during Sep-2014. It was reported that MD AND HER CHILDREN RECEIVED FLUMIST QUADRIVALENT AND THEN TESTED POSTIVE INFLUENZA which started during Jan-2015. The patient recovered from the event of MD AND HER CHILDREN RECEIVED FLUMIST QUADRIVALENTT AND THEN TESTED POSITIVE INFLUENZA on an unspecified date. The report was considered to be non-serious by reporter.
Age: 60.0
Sex: F
Vaccine: FLUN4
Symptoms: Influenza
Clinical narrative: The spontaneous report has been received from a nurse practitioner concerning a female patient of 60 years. The patient's medical history, concurrent diseases and concomitant medications were not provided. The patient received FLUMIST quadrivalent (intranasal) on 12-Oct-2014. The patient was administered FLUMIST quadrivalent on 12-Oct-2014 and had the flu on 13-Jan-2015. The outcome of the event of patient administered FLUMIST quadrivalent on 12Oct14 and has the flu on Jan13 was unknown. The reporter assessed the event patient administered FLUMIST quadrivalent on 12Oct14 and has the flu on Jan13 to be non serious.
Age: 37.0
Sex: U
Vaccine: FLUN4
Symptoms: Influenza A virus test positive
Clinical narrative: A report has been received from a Health Professional concerning a 37 year old, subject of unknown gender, who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on 12-Oct-2014. The patient experienced PATIENT ADMINISTERED FLUMIST ON 10/12/2014 TESTED POSITIVE WITH FLU A ON 01/2015. The patient experienced PATIENT ADMINISTERED FLUMIST ON 10/12/2014 TESTED POSITIVE WITH FLU A ON 01/2015 which started during Jan-2015. The outcome of the event of PATIENT ADMINISTERED FLUMIST ON 10/12/2014 TESTED POSITIVE WITH FLU A ON 01/2015 is unknown. The report was considered to be non-serious.
Age: 40.0
Sex: F
Vaccine: FLUN4
Symptoms: Influenza
Clinical narrative: A spontaneous report has been receiving from a Health professional concerning a 41 year old, Female patient. Concomitant medications included desogestrel, ethinylestradiol for birth control. On 05-Nov-2014, the patient started receiving nasal FLUMIST (intranasal), 0.2 millilitres, daily for flu prevention. On 15-Dec-2014, The patient experienced moderate flu after receiving FLUMIST. On 18-Dec-2015 event of flu after receiving FLUMIST was recovered. The reporter considered the event of flu after receiving FLUMIST to be non-serious.
Age: 11.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Health Professional concerning an 11 year old, Male subject who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on 06-Feb-2015. The patient had been administered expired FLUMIST which started on 06-Feb-2015. The outcome of the event of EXPIRED FLUMIST is unknown. The report was considered to be non-serious. Follow-up of insignificant information received by AstraZeneca/MedImmune 12-Feb-2015 from consumer: Patient demographics information updated. Narrative amended.
Age: 9.0
Sex: F
Vaccine: FLUN4
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: A consumer report has been received. The report concerns an Adult, Female consumer, who had been receiving nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on Dec-2014. The patient experienced PAIN IN HANDS and SWELING ON HANDS. At the time of reporting, the event of PAIN IN HANDS and SWELLING ON HANDS was ongoing. The report was considered to be non-serious.
Age: 9.0
Sex: F
Vaccine: FLUN4
Symptoms: Erythromelalgia
Clinical narrative: A consumer report has been received. The report concerns a 9 year old, Female consumer, who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started during Oct-2014. The patient experienced ERYTHROMELALGIA which started on 02-Dec-2014. The outcome of the event of ERYTHROMELALGIA is unknown. The report was considered to be non-serious.
Age: 11.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Health Professional concerning an 11 year old, Female subject who had been receiving Nasal FLUMIST (INTRANASAL) FLUMIST (INTRANASAL) started on 17-Feb-2015. It was reported that inadvertently administered an expired dose of FLUMIST to a patient. The outcome of the event of EXPIRED FLUMIST is unknown. The report was considered to be non-serious.
Age: 8.0
Sex: F
Vaccine: FLUN4
Symptoms: Gastroenteritis
Clinical narrative: A consumer report has been received. The report concerns a patient born on 19-Dec-2006, Female consumer who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on 16-Jan-2015. The patient experienced ACUTE GASTROENTERITIS. At the time of reporting, the event of ACUTE GASTROENTERITIS was ongoing. The report was considered to be non-serious. Summary of follow-up information received by AstraZeneca/Med Immune 20-Mar-2015 by consumer. New event acute gastroenteritis added. Events diarrhea (on and off for three weeks since receiving FLUMIST), vomiting (on and off for three weeks since receiving FLUMIST, abdominal pain (on an off for three weeks since receiving FLUMIST), light fever (on and off for three weeks since receiving FLUMIST) deleted. Form completed date updated. Start date for suspect drug updated on 16-Jan-2015 and lot number added. Narrative updated.
Sex: F
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Health Professional concerning a Female subject, who had been receiving Nasal QLAIV (INTRANASAL). Concomitant medications included HEPATITIS A VACCINE and TYPHOID VACCINE. FLUMIST (INTRANASAL) started on 19-Feb-2015. It was reported that the patient was unintentionally administered expired FLUMIST which started on 19-Feb-2015. The outcome of the event of UNINTENTIONAL ADMINISTRATION OF EXPIRED PRODUCT is unknown. The report was considered to be non-serious. The reporter considered that the event of unintentional administration of expired product was not related to QLAIV. The company physician considered that the event of unintentional administration of expired product was not related to QLAIV.
Age: 10.0
Sex: F
Vaccine: FLUN4
Symptoms: Chest X-ray abnormal, Influenza virus test positive, Malaise, Oropharyngeal pain, Pneumonia
Clinical narrative: A spontaneous report had been received from consumer via medical representative concerned a 10 year old, Female patient. The patient medical history and concomitant drugs were not reported. On 24-Sep-2014, patient had been received Nasal FLUMIST (intranasal) for unknown indication. Patient was not feeling well. She had developed a sore throat and mucus. On 21-Feb-2015, patient had developed a productive cough and a fever up to 103 degrees F. She tested positive for influenza and a chest x-ray revealed left lower lobe pneumonia. She was prescribed amoxicillin for 5 days in addition to alternating TYLENOL and MOTRIN for fever. By 23-Feb-2015, she was better and her fever had resolved. She went to school and was feeling well. At the time of reporting, the events of influenza and left lower lobe pneumonia was improving. The report was considered to be non-serious by reporter.
Age: 10.0
Sex: F
Vaccine: FLUN4
Symptoms: Productive cough, Pyrexia, Secretion discharge
Clinical narrative: A spontaneous report had been received from consumer via medical representative concerned a 10 year old, Female patient. The patient medical history and concomitant drugs were not reported. On 24-Sep-2014, patient had been received Nasal FLUMIST (intranasal) for unknown indication. Patient was not feeling well. She had developed a sore throat and mucus. On 21-Feb-2015, patient had developed a productive cough and a fever up to 103 degrees F. She tested positive for influenza and a chest x-ray revealed left lower lobe pneumonia. She was prescribed amoxicillin for 5 days in addition to alternating TYLENOL and MOTRIN for fever. By 23-Feb-2015, she was better and her fever had resolved. She went to school and was feeling well. At the time of reporting, the events of influenza and left lower lobe pneumonia was improving. The report was considered to be non-serious by reporter.
Age: 13.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A solicited report has been received from a Health Professional concerning a 13 year old, Male subject, who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on an unknown date. The patient experienced ACCIDENTALLY ADMINISTERED EXPIRED FLUMIST TO A PATIENT which started on 24-Feb-2015. The outcome of the event of ACCIDENTALLY ADMINISTERED EXPIRED FLUMIST TO A PATIENT is unknown. The report was considered to be non-serious.